Colonic Diseases  >>  NGC-capecitabine (PCS6422)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
NGC-capecitabine (PCS6422) / Processa Pharma
NCT00827580: Eniluracil Hand Foot Syndrome

Terminated
1
3
US
Eniluracil
West Virginia University
Breast Cancer, Colon Cancer
09/09
09/09

Download Options